Anika Therapeutics | ANIK - Cost Of Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Anika Therapeutics

Anika Therapeutics reported $15.08M in Cost of Sales for its fiscal quarter ending in March of 2023.


Cost Of Sales Change
Abbott ABT:US USD 4.32B 209M
Acorda Therapeutics ACOR:US USD 3.23M 1.33M
Agenus AGEN:US USD 2.29M 5.4M
Agios Pharmaceuticals AGIO:US USD 554K 141K
Anika Therapeutics ANIK:US USD 15.08M 410K
Halozyme Therapeutics HALO:US USD 35.17M 6.95M
Heron Therapeutics HRTX:US USD 16.85M 4.23M
Immunogen IMGN:US 626K 450K
Insmed INSM:US USD 13.83M 761K
Integra LifeSciences IART:US USD 141.91M 8.16M
J&J JNJ:US USD 8.4B 684M
Karyopharm Therapeutics KPTI:US USD 1.35M 517K
Ligand Pharmaceuticals LGND:US USD 3.72M 17.9M
MacroGenics MGNX:US USD 3.52M 1.73M
Merit Medical Systems MMSI:US USD 159.2M 340K
Peregrine Pharmaceuticals PPHM:US USD 28.19M 2.42M
Rigel Pharmaceuticals RIGL:US USD 977K 635K
Smith & Nephew PLC SN/:LN 767M 6M
Stryker SYK:US USD 1.76B 177M
Surmodics SRDX:US USD 5.74M 471K
Veracyte VCYT:US USD 26.23M 602K
Zimmer Biomet Holdings Inc ZBH:US USD 500.8M 19.5M